{
  "type": "ref",
  "text": "The aim of the present study was to clarify how expression of p53 protein participates in angiogenesis and whether the coexpression of VEGF and p53 protein has a significance for angiogenesis and the clinicopathological features in esophageal squamous cell carcinoma (SCC).\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "The aim",
        "the present study",
        "expression",
        "p53 protein",
        "angiogenesis",
        "the coexpression",
        "VEGF",
        "p53 protein",
        "a significance",
        "angiogenesis",
        "esophageal squamous cell carcinoma",
        "(SCC"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the purpose of the present study?",
          "What was the aim of the study?",
          "What part of p53 protein is involved in angiogenesis?",
          "What protein is involved in angiogenesis?",
          "What is the purpose of the present study?",
          "What is a significant factor in angiogenesis?",
          "What protein is involved in angiogenesis?",
          "What protein is involved in angiogenesis?",
          "What is the coexpression of VEGF and p53 protein for angiogenesis?",
          "What is the purpose of the present study?",
          "What is SCC?",
          "What is the name of the esophageal squamous cell carcinoma"
        ]
      }
    }
  },
  "asked": {
    "How many parameters were more frequently observed in the SCC with VEGF/p53 co": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00905686616897583,
        "ground_truth": {
          "two": {
            "bertscore": 0.7294576168060303,
            "f1": 0
          }
        }
      }
    },
    "What is the most frequently observed group with VEGF/p53 coexpression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0006961822509765625,
        "ground_truth": {
          "SCC": {
            "bertscore": 0.7027845978736877,
            "f1": 0
          }
        }
      }
    },
    "What parameters were more frequently observed in the SCC with VEGF/p53 coexpression": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0372920036315918,
        "ground_truth": {
          "The two parameters": {
            "bertscore": 0.6587644219398499,
            "f1": 0
          }
        }
      }
    },
    "In which group were the two parameters more frequently observed?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0024328231811523438,
        "ground_truth": {
          "the SCC": {
            "bertscore": 0.6916001439094543,
            "f1": 0
          }
        }
      }
    },
    "What is the most common coexpression of VEGF/p53?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0018376708030700684,
        "ground_truth": {
          "VEGF/p53 coexpression": {
            "bertscore": 0.6285467743873596,
            "f1": 0
          }
        }
      }
    },
    "What was more frequently observed in the SCC with VEGF/p53 coexpression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.020455777645111084,
        "ground_truth": {
          "the coexpression": {
            "bertscore": 0.673826277256012,
            "f1": 0
          }
        }
      }
    }
  }
}